Consulting Services
For Investors
- Lucid Diligence Briefs
Case Studies
Insights
- Conference Previews
BioPharma and Tech News
LucidSearch
QuickAnswers

Contact Us

Search

IHH Healthcare

Artificial_Intelligence

Latest Artificial Intelligence and Digital Health News - Sept 23rd to Oct 6th 2025

Watch Our Video Summary Capturing Top AI in Healthcare and Digital Health News…

Artificial_Intelligence

Artificial Intelligence and Digital Health Weekly News - October 6th 2025

AI in Healthcare and Digital Health Update: NICE reforms, AI weight-loss gains,…

Categories

Endocrinology News
Immunology News
Our Insights
Hematology News
Case studies
Oncology News
BioPharma and Tech News
Lucid Diligence Brief
BioPharma Strategy, CI and AI Guides
Conference Previews
AI in Healthcare and Digital Health
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news
Obesity News

Recent Posts

Obesity Today—November 18, 2025
Endocrinology Video Recap—November 18, 2025
Endocrinology Today—November 18, 2025
Lucid Diligence Brief: Johnson & Johnson acquires Halda Therapeutics
Oncology Today—November 17, 2025

Tags

ALS therapy Alvotech Ambient Air Quality Directive Apple Aptose Biosciences Ascletis Pharma ATR inhibitor CARsgen Therapeutics City of Hope CMC COPD therapy CSU deoxycytidine kinase Diabetic retinopathy EHMSG Eli Lilly Mounjaro embolism Everest Medicines formulary IHH Healthcare IL-23 pathway ILD safety Intellia Therapeutics in vivo CAR-T IO Biotech iopofosine I-131 market landscape Medipal NMRC Olumiant permethrin-treated wraps prior authorization PUL v2.0 Rocky Mountain MS Clinic safusidenib SleepSpace telomeres Thymidine kinase 2 deficiency trastuzumab deruxtecan ultrasound ablation Umoja VarmX Virometix xolair Zokinvy

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Obesity Today—November 18, 2025
Endocrinology Video Recap—November 18, 2025
Endocrinology Today—November 18, 2025
Lucid Diligence Brief: Johnson & Johnson acquires Halda Therapeutics
Oncology Today—November 17, 2025

TAGS

ALS therapy Alvotech Ambient Air Quality Directive Apple Aptose Biosciences Ascletis Pharma ATR inhibitor CARsgen Therapeutics City of Hope CMC COPD therapy CSU deoxycytidine kinase Diabetic retinopathy EHMSG Eli Lilly Mounjaro embolism Everest Medicines formulary IHH Healthcare IL-23 pathway ILD safety Intellia Therapeutics in vivo CAR-T IO Biotech iopofosine I-131 market landscape Medipal NMRC Olumiant permethrin-treated wraps prior authorization PUL v2.0 Rocky Mountain MS Clinic safusidenib SleepSpace telomeres Thymidine kinase 2 deficiency trastuzumab deruxtecan ultrasound ablation Umoja VarmX Virometix xolair Zokinvy

Consulting Services
For Investors
- Lucid Diligence Briefs
Case Studies
Insights
- Conference Previews
BioPharma and Tech News
LucidSearch
QuickAnswers

© 2025 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy